Bristol Myers’ Lung Drug Works. Now Explain the Dose Split.
Admilparant hit Phase 3 FVC at 60mg, but the 120mg miss complicates the FDA story.
Category: Economy
FieldAI’s $10B Raise Tells You Where the Robot Money Is Going
After Firmus’s failed IPO, private capital is abandoning AI data centres for physical AI. Here are the listed names in the path of that shift.
TikTok’s Ad Dollars Just Got Kicked Out of Meta. Snap and Pinterest Are First in Line.
Meta’s ByteDance ad ban raises a reallocation question, and one challenger looks better positioned than the other.
When OFAC Says No, Even Carlyle Walks Away From Lukoil
A $22 billion deal fell apart, and the Oct. 22 deadline is real
Federal Water Money Is Gone. Modular RO Plants Fill the Gap.
The IIJA fiscal-year rollover is accelerating a shift toward subscription-style water delivery.
Valero Is Up 44% Since June. Does China’s Diesel News Change Anything?
China’s October fuel exports look modest, but three other risks deserve equal attention ahead of Valero’s Oct. 22 earnings report.
Three Catalysts Will Define Markets This Week
ISM services Monday, Fed minutes Wednesday, and PepsiCo Thursday tighten the October decision window into five days.
Toyota Grew Sales 8.4% in September. Who Paid?
Incentives hit 6.9% of sticker. Not every automaker needed them.
Amazon Is Paying to Keep Calvert Cliffs Running. That Tells You Everything About Nuclear’s Real Value.
AI demand cannot wait for new reactors. Existing plants are the only firm clean power you can contract today.
Delta’s Q2 Premium Shift. Q3 Tells Us If It Holds.
Premium ticket revenue beat main cabin in Q2. Delta reports Oct. 9.